From: Association between serum hydrogen sulfide concentrations and dysglycemia: a population-based study
NFG-NGT (n = 511) | IIFG (n = 73) | IIGT (n = 65) | Combined IFG-IGT (n = 38) | T2DM (n = 111) | |
---|---|---|---|---|---|
Age (y) | 41.0 ± 12.6 | 47.1 ± 12.2 | 50.1 ± 14.1 | 55.8 ± 13.8 | 56.1 ± 12.5 |
Men (%) | 46.6 | 50.7 | 47.7 | 50.0 | 53.2 |
FH (%) | 7.4 | 12.5 | 7.8 | 10.8 | 16.2 |
BMI (kg/m2) | 27.1 ± 5.0 | 30.4 ± 5.9 | 28.9 ± 4.9 | 29.8 ± 4.2 | 29.9 ± 4.8 |
WC (cm) | 91.4 ± 11.7 | 99.3 ± 12.7 | 96.5 ± 10.8 | 100.0 ± 9.8 | 101.2 ± 11.2 |
SBP (mm Hg) | 109 ± 13 | 118 ± 15 | 117 ± 18 | 121 ± 18 | 125 ± 17 |
DBP (mm Hg) | 74 ± 9 | 79 ± 8 | 78 ± 11 | 75 ± 8 | 79 ± 8 |
FSG (mg/dL) | 87.9 ± 6.5 | 104.4 ± 4.6 | 90.7 ± 5.1 | 107 ± 5.3 | 152.9 ± 59.5 |
2 h-SG (mg/dL) | 98.9 ± 19.9 | 107.5 ± 18.5 | 156.4 ± 13.9 | 167.1 ± 15.7 | 243.7 ± 89.7b |
TG (mg/dL)a | 113 (80–159) | 128 (98–194) | 159 (123–204) | 146 (120–213) | 165 (118–224) |
HDL-C (mg/dL) | 48 ± 10 | 45 ± 11 | 44 ± 11 | 44 ± 11 | 43 ± 10 |
Serum H2S (µmol/L) a | 42.9 (22.2–81.0) | 36.9 (17.4–88.1) | 33.4 (19.3–70.9) | 36.1 (9.3–81.1) | 36.5 (18.9–71.1) |